InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: invest2992 post# 259362

Tuesday, 03/31/2020 10:27:42 PM

Tuesday, March 31, 2020 10:27:42 PM

Post# of 425918
As if we won the patent suit but minus the 200 million or so we'd have to pay Dr Reddy and Hikma.

The point of the Teva contingency is to make sure that they will know that Teva will have the market and not Hikma or Dr. Reddy... and that as such they should settle.

But even should they not settle we'd still be better off with a generic partner than with generic competitors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News